SCHEMBL20108899

SCHEMBL20108899

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc3ccc4ccc(-c5ccccn5)nc4c3n2)c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.40
LMNA P02545 5/20 0.37
KDM4E B2RXH2 4/20 0.37
HTT P42858 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
TDP1 Q9NUW8 2/20 0.37
TP53 P04637 2/20 0.37
ALOX15 P16050 2/20 0.37
CCR1 P32246 2/20 0.37
CCR5 P51681 2/20 0.37
CCR8 P51685 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPK1 P28482 2/20 0.37
ALPL P05186 1/20 0.37
HSP90AA1 P07900 1/20 0.37
ALPI P09923 1/20 0.37
ALPG P10696 1/20 0.37
TOP1 P11387 1/20 0.36
CYP3A4 P08684 4/20 0.36
PADI1 Q9ULC6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20108912 0.99 CYP2C9 (0.39) CYP2C9LMNAKDM4EHTTL3MBTL1
SCHEMBL20108907 0.91 CYP2C9 (0.40) CYP2C9LMNAKDM4EHTTL3MBTL1
SCHEMBL20108904 0.91 TOP1 (0.41) CYP2C9LMNAKDM4EHTTL3MBTL1
SCHEMBL20108840 0.90 LMNA (0.41) CYP2C9LMNAKDM4EHTTL3MBTL1
SCHEMBL20108850 0.89 LMNA (0.40) CYP2C9LMNAKDM4EHTTL3MBTL1
SCHEMBL20108871 0.85 TOP1 (0.41) CYP2C9TOP1CYP3A4MEN1KMT2A
SCHEMBL20108870 0.84 LMNA (0.36) CYP2C9LMNAKDM4EHTTL3MBTL1
SCHEMBL20108875 0.84 TOP1 (0.41) CYP2C9TOP1CYP3A4MEN1KMT2A
SCHEMBL20108910 0.82 CYP2C9 (0.39) CYP2C9LMNAKDM4EHTTL3MBTL1
SCHEMBL20108838 0.81 LMNA (0.36) CYP2C9LMNAKDM4EHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2021-10-26 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD2, OCIAD1, PPOX CYP2C9 400/4885LMNA 3418/4885KDM4E 2220/4885
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD2, OCIAD1, PPOX CYP2C9 400/4885LMNA 3418/4885KDM4E 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.